Works matching AU Sakai, Hiroshi

Results: 162
    1
    2
    3
    4

    A Randomized Phase 2 Study of 5-Aminolevulinic Acid Hydrochloride and Sodium Ferrous Citrate for the Prevention of Nephrotoxicity Induced by Cisplatin-Based Chemotherapy of Lung Cancer.

    Published in:
    Oncology, 2022, v. 100, n. 11, p. 620, doi. 10.1159/000526977
    By:
    • Kawamura, Kodai;
    • Matsushima, Hidekazu;
    • Sakai, Hiroshi;
    • Iwashima, Akira;
    • Nakamura, Sukeyuki;
    • Kojima, Tohru;
    • Sasaki, Shinichi;
    • Shigenaga, Takehiko;
    • Natsume, Ichiro;
    • Sasaki, Takaaki;
    • Ohsaki, Yoshinobu;
    • Iwanaga, Kentaro;
    • Nishi, Koichi;
    • Mitsuishi, Yoichiro;
    • Taniguchi, Hirokazu;
    • Sato, Kazuhiro;
    • Yamauchi, Mitsugu;
    • Nakajima, Motowo;
    • Takahashi, Kazuhisa
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*.

    Published in:
    Cancer Science, 2021, v. 112, n. 12, p. 5000, doi. 10.1111/cas.15144
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    13

    First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset.

    Published in:
    Cancer Science, 2020, v. 111, n. 12, p. 4480, doi. 10.1111/cas.14647
    By:
    • Satouchi, Miyako;
    • Nosaki, Kaname;
    • Takahashi, Toshiaki;
    • Nakagawa, Kazuhiko;
    • Aoe, Keisuke;
    • Kurata, Takayasu;
    • Sekine, Akimasa;
    • Horiike, Atsushi;
    • Fukuhara, Tatsuro;
    • Sugawara, Shunichi;
    • Umemura, Shigeki;
    • Saka, Hideo;
    • Okamoto, Isamu;
    • Yamamoto, Nobuyuki;
    • Sakai, Hiroshi;
    • Kishi, Kazuma;
    • Katakami, Nobuyuki;
    • Horinouchi, Hidehito;
    • Hida, Toyoaki;
    • Okamoto, Hiroaki
    Publication type:
    Article
    14
    15

    KEYNOTE‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer.

    Published in:
    Cancer Science, 2019, v. 110, n. 3, p. 1012, doi. 10.1111/cas.13932
    By:
    • Nishio, Makoto;
    • Takahashi, Toshiaki;
    • Yoshioka, Hiroshige;
    • Nakagawa, Kazuhiko;
    • Fukuhara, Tatsuro;
    • Yamada, Kazuhiko;
    • Ichiki, Masao;
    • Tanaka, Hiroshi;
    • Seto, Takashi;
    • Sakai, Hiroshi;
    • Kasahara, Kazuo;
    • Satouchi, Miyako;
    • Han, Shi Rong;
    • Noguchi, Kazuo;
    • Shimamoto, Takashi;
    • Kato, Terufumi
    Publication type:
    Article
    16

    Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

    Published in:
    Cancer Science, 2017, v. 108, n. 5, p. 1000, doi. 10.1111/cas.13225
    By:
    • Hida, Toyoaki;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Ohe, Yuichiro;
    • Nokihara, Hiroshi;
    • Sakai, Hiroshi;
    • Satouchi, Miyako;
    • Nakagawa, Kazuhiko;
    • Takenoyama, Mitsuhiro;
    • Isobe, Hiroshi;
    • Fujita, Shiro;
    • Tanaka, Hiroshi;
    • Minato, Koichi;
    • Takahashi, Toshiaki;
    • Maemondo, Makoto;
    • Takeda, Koji;
    • Saka, Hideo;
    • Goto, Koichi;
    • Atagi, Shinji;
    • Hirashima, Tomonori
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24

    Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and ONO‐4538‐06 studies.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 11, p. 5183, doi. 10.1002/cam4.2411
    By:
    • Horinouchi, Hidehito;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Saka, Hideo;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Sumiyoshi, Naoki
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31

    Chang's Conjecture and weak square.

    Published in:
    Archive for Mathematical Logic, 2013, v. 52, n. 1/2, p. 29, doi. 10.1007/s00153-012-0305-8
    By:
    • Sakai, Hiroshi
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39

    Characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progression.

    Published in:
    Expert Opinion on Pharmacotherapy, 2018, v. 19, n. 10, p. 1049, doi. 10.1080/14656566.2018.1484903
    By:
    • Hosomi, Yukio;
    • Tanai, Chiharu;
    • Yoh, Kiyotaka;
    • Goto, Yasushi;
    • Sakai, Hiroshi;
    • Kato, Terufumi;
    • Kaburagi, Takayuki;
    • Nishio, Makoto;
    • Kim, Young Hak;
    • Inoue, Akira;
    • Hasegawa, Yoshinori;
    • Isobe, Hiroshi;
    • Tomizawa, Yoshio;
    • Mori, Yoshiaki;
    • Minato, Koichi;
    • Yamada, Kazuhiko;
    • Ohashi, Yasuo;
    • Kunitoh, Hideo
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46

    Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing.

    Published in:
    International Journal of Oncology, 2017, v. 50, n. 5, p. 1579, doi. 10.3892/ijo.2017.3935
    By:
    • GOU YAMAMOTO;
    • MARI KIKUCHI;
    • SHIHO KOBAYASHI;
    • YOSHIKO ARAI;
    • KENJI FUJIYOSHI;
    • TOMOKAZU WAKATSUKI;
    • MIHO KAKUTA;
    • YUKI YAMANE;
    • YOSHIHITO IIJIMA;
    • HIDEAKI MIZUTANI;
    • YUKI NAKAJIMA;
    • JUNKO SUDO;
    • HIROYASU KINOSHITA;
    • FUTOSHI KURIMOTO;
    • HIROHIKO AKIYAMA;
    • HIDETAKA URAMOTO;
    • HIROSHI SAKAI;
    • YOSHITO AKAGI;
    • KIWAMU AKAGI
    Publication type:
    Article
    47
    48
    49
    50